Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
Clinical trial NCT05933720 · RECRUITING
Trial details
- NCT number
- NCT05933720
- Sponsor
- Ryazan State Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2026-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.